CapsoVision, Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
CapsoVision, Inc (CV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $2.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-13
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $1.32M.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $739.00K.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $3.48M.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $135.00K.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $4.53M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.06M 10-Q · filed 2026-08-13 | $5.54M derived: sum of 3 quarters · filed 2026-08-13 | $5.68M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $739.00K 10-Q · filed 2026-05-14 | $4.22M derived: sum of 2 quarters · filed 2026-05-14 | $4.36M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $3.62M derived: sum of 2 quarters · filed 2026-03-26 | $4.53M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.05M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $914.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |